Amicus Therapeutics, Inc. (0HF9.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
As of 02:18PM GMT. Market open.
| Previous close | 11.28 |
| Open | 11.14 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 11.14 - 11.14 |
| 52-week range | 11.14 - 11.14 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 3.266B |
| Beta (5Y monthly) | 0.86 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.07 |
| Earnings date | 08 May 2023 - 12 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Amicus (FOLD) Q4 Earnings Miss, Galafold Sales Beat Estimates
Amicus (FOLD) posts a wider-than-expected fourth-quarter loss but strong sales of its solely marketed drug Galafold drive the top line.
- Zacks
Amicus Therapeutics (FOLD) Reports Q4 Loss, Tops Revenue Estimates
Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of -46.15% and 1.44%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Swelling losses haven't held back gains for Amicus Therapeutics (NASDAQ:FOLD) shareholders since they're up 39% over 1 year
These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But if you pick...
© 2023 Yahoo. All rights reserved.
